3D Santé: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
3D Santé
Largest movements
- Financial fixed assets +€130,162
up €130,162 (+77.0%), from €169,008 to €299,170
- Receivables within one year -€76,491
down €76,491 (-44.3%), from €172,831 to €96,341
- Cash +€24,986
up €24,986 (+1,683%), from €1,485 to €26,471
mainly Other debts (+€188,312) and Receivables within one year (+€76,491)
- Other debts +€188,312
up €188,312 (+195%), from €96,487 to €284,799
- Profit (loss) carried forward -€110,671
down €110,671 (-459%), from -€24,108 to -€134,779
- Turnover +€24,950
new in 2025: €24,950
- Gross operating margin +€24,511
new in 2025: €24,511
- Financial income +€2,000
new in 2025: €2,000
- Other operating charges +€435
new in 2025: €435
- Purchases and services +€381
new in 2025: €381
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €345,062 | €423,315 | +€78,253 | +22.7% |
| Fixed assets | 21/28 | €169,008 | €299,170 | +€130,162 | +77.0% |
| Financial fixed assets | 28 | €169,008 | €299,170 | +€130,162 | +77.0% |
| Current assets | 29/58 | €176,054 | €124,144 | -€51,910 | -29.5% |
| Amounts receivable within one year | 40/41 | €172,831 | €96,341 | -€76,491 | -44.3% |
| Other amounts receivable | 41 | €172,831 | €96,341 | -€76,491 | -44.3% |
| Current investments | 50/53 | €405 | - | -€405 | |
| Cash at bank and in hand | 54/58 | €1,485 | €26,471 | +€24,986 | +1,683% |
| Deferred charges and accrued income | 490/1 | €1,333 | €1,333 | = | 0.0% |
| Total equity and liabilities | 10/49 | €345,062 | €423,315 | +€78,253 | +22.7% |
| Equity | 10/15 | €248,575 | €137,904 | -€110,671 | -44.5% |
| Contributions | 10/11 | €247,894 | €247,894 | = | 0.0% |
| Reserves | 13 | €24,789 | €24,789 | = | 0.0% |
| Non-distributable reserves | 130/1 | €24,789 | €24,789 | = | 0.0% |
| Reserves not available under the articles | 1311 | €24,789 | €24,789 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€24,108 | -€134,779 | -€110,671 | -459% |
| Amounts payable | 17/49 | €96,487 | €285,411 | +€188,924 | +196% |
| Amounts payable within one year | 42/48 | €96,487 | €285,411 | +€188,924 | +196% |
| Trade debts | 44 | - | €612 | +€612 | |
| Suppliers | 440/4 | - | €612 | +€612 | |
| Other amounts payable | 47/48 | €96,487 | €284,799 | +€188,312 | +195% |
| Turnover | 70 | - | €24,950 | +€24,950 | |
| Goods, raw materials, services and sundry goods | 60/61 | - | €381 | +€381 | |
| Other operating charges | 640/8 | - | €435 | +€435 | |
| Gross operating margin | 9900 | - | €24,511 | +€24,511 | |
| Operating profit (loss) | 9901 | - | €24,077 | +€24,077 | |
| Financial income | 75/76B | - | €2,000 | +€2,000 | |
| Recurring financial income | 75 | - | €2,000 | +€2,000 | |
| Financial charges | 65/66B | €197 | - | -€197 | |
| Recurring financial charges | 65 | €197 | - | -€197 | |
| Profit (loss) for the period before taxes | 9903 | -€197 | €26,077 | +€26,274 | |
| Profit (loss) for the period | 9904 | -€197 | €26,077 | +€26,274 | |
| Profit (loss) for the period to be appropriated | 9905 | -€197 | €26,077 | +€26,274 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.